Amphastar Pharmaceuticals AMPH Earnings Call Transcripts

NASDAQ AMPH
$29.38 +0.89 (+3.12%)
At close: Nov 9, 2026 · 4:00 PM EST
16 earnings calls on file for Amphastar Pharmaceuticals, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Amphastar Pharmaceuticals Q2 2026 Earnings Call

Aug 6, 2026 4,074 words · 18 min read
  • Dan DischnerSenior Vice President of Corporate Communications
  • Tony MarrsExecutive Vice President of Regulatory Affairs and Clinical Operations
  • William PetersChief Financial Officer and Executive Vice President of Finance
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Amphastar Pharmaceuticals Earnings Call Transcripts

Calls16
LatestAug 6, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 16 Amphastar Pharmaceuticals transcripts Register to get access to Amphastar Pharmaceuticals’s earnings call transcripts.